ArticleGenes & diseases2022

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma.

Chaoqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.